Enriqueta Felip, MD, PhD / David Harpole, MD - Reflecting on the Role of Perioperative Immunotherapeutic Regimens for Resectable Non–Small-Cell Lung Cancer: Evaluating the Evidence to Determine Better Pathways of Care

Please visit answersincme.com/XQE860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, two experts in non–small-cell lung cancer (NSCLC) discuss perioperative immunotherapeutic approaches in patients with resectable NSCLC. Upon completion of this activity, participants should be better able to: Describe the rationale for perioperative immunotherapeutic approaches in patients with resectable NSCLC; Outline the clinical impact of perioperative immunotherapeutic approaches in patients with resectable NSCLC; and Identify practical strategies to optimize the care of patients with resectable NSCLC, based on the current and emerging clinical data.